Photo: ReutersBritish scientists have urged European countries to take note of interim data showing what they described as "remarkable" effectiveness of a single dose of Pfizer's or AstraZeneca's Covid-19 vaccines in frail and elderly people. Some European countries, including Germany, Italy and France, are seeing a relatively slow roll-out of AstraZeneca's Covid-19 vaccine. Adam Finn, a professor of paediatrics and the study's chief investigator, said the results showed Britain's fast-paced Covid vaccine roll-out "is working better than we could have hoped". "This study is much more important for non-UK countries than it is for the UK," he told reporters at a briefing. "There are lots of doses of AstraZeneca vaccine available in European countries and they are not being given to people over the age of 65 ... for lack of data," he said.

Source: Otago Daily Times March 03, 2021 19:52 UTC